As of November 7, 2026, 6 holders' latest Schedule 13D or 13G filings report owning 5% or more of Medline Inc. The largest reported stake is Mozart Holdco, Inc.'s, at 22.4%. 15 filings are on record since December 29, 2025 (Schedule 13G, February 13, 2026).
Sell to companies like Medline Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Holder: GIC Private Limited · Percent: 8.49% · SCHEDULE 13G/A
- · Holder: GIC Private Limited · Percent: 13.03% · SCHEDULE 13G/A
- · Reporting person: Hellman & Friedman Capital Partners X (Parallel), L.P. · Sole voting: 61,054,619 · Sole dispositive: 61,054,619 · SCHEDULE 13G/A, 2026-08-11
- · Reporting person: BX Mozart ML-2 Holdco L.P. · Sole voting: 89,537,913 · Shared voting: 0 · Sole dispositive: 89,537,913 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-08-07
- · Holder: Fmr LLC · Percent: 5.5% · SCHEDULE 13G
Medline Inc. has 15 Schedule 13D or 13G filings on record since 2025-12-29. 6 holders' latest filing reports 5% or more of class a common stock, par value $0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Mozart Holdco, Inc. | 22.4% | 234,308,304 | SCHEDULE 13G, 2026-02-13 | 2025-12-31 |
| Carlyle Group Inc. | 20.6% | 187,083,713 | SCHEDULE 13G/A, 2026-05-15 | 2026-03-31 |
| Bma Viii L.L.C. | 16.5% | 153,327,675 | SCHEDULE 13G/A, 2026-08-07 | 2026-06-30 |
| Hellman & Friedman Investors X, L.P. | 16% | 153,327,675 | SCHEDULE 13G/A, 2026-08-11 | 2026-06-30 |
| GIC Private Limited | 8.49% | 74,634,102 | SCHEDULE 13G/A, 2026-11-06 | 2026-11-04 |
| Fmr LLC | 5.5% | 46,929,204 | SCHEDULE 13G, 2026-08-06 | 2026-06-30 |
| Abu Dhabi Investment Authority | 4.9% | 41,355,340 | SCHEDULE 13G/A, 2026-05-07 | 2026-03-31 |
Holding shares or following this stake? See who's behind Medline Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Medline Inc. and the records around it.
Medline Inc. elsewhere on the record
- Leadership changes Jul 2026
- IPO filing May 2026
- Who owns it
Companies that share a holder
- Abu Dhabi Investment Authority also filed stake reports on 7 other companies: Jersey Mike's Subs Inc. (Oct 2026), Eikon Therapeutics, Inc. (Oct 2026), AGL Private Credit Income Fund (Sep 2026)
- BX Mozart ML-2 Holdco L.P. also filed stake reports on 7 other companies: Corebridge Financial, Inc. (Nov 2026), Jersey Mike's Subs Inc. (Nov 2026), VARAGON CAPITAL CORPORATION (Oct 2026)
- Carlyle Group Inc. also filed stake reports on 7 other companies: SunPower Inc. (Aug 2026), Q32 Bio Inc. (Jul 2026), StandardAero, Inc. (May 2026)
Watch Medline Inc.
Get an email when Medline Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Medline Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Medline Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Medline Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
25 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| BX Mozart ML-2 Holdco L.P. | 89,537,913 | 0 | 89,537,913 | 0 | SCHEDULE 13G/A, 2026-08-07 |
| BX Mozart ML-1 Holdco L.P. | 44,780,813 | 0 | 44,780,813 | 0 | SCHEDULE 13G/A, 2026-08-07 |
| Mozart Aggregator II UNLV Holdco L.P. | 10,250,904 | 0 | 10,250,904 | 0 | SCHEDULE 13G/A, 2026-08-07 |
| Mozart Aggregator UNLV Holdco L.P. | 6,767,578 | 0 | 6,767,578 | 0 | SCHEDULE 13G/A, 2026-08-07 |
| Mozart Aggregator II LP | 91,528,380 | 0 | 91,528,380 | 0 | SCHEDULE 13G/A, 2026-08-07 |
| BX Mozart ML-2 Holdco GP L.L.C. | 89,537,913 | 0 | 89,537,913 | 0 | SCHEDULE 13G/A, 2026-08-07 |
| BX Mozart ML-1 Holdco GP L.L.C. | 44,780,813 | 0 | 44,780,813 | 0 | SCHEDULE 13G/A, 2026-08-07 |
| BCP Mozart Aggregator L.P. | 44,780,813 | 0 | 44,780,813 | 0 | SCHEDULE 13G/A, 2026-08-07 |
| Blackstone Management Associates VIII L.P. | 101,779,284 | 0 | 101,779,284 | 0 | SCHEDULE 13G/A, 2026-08-07 |
| BCP 8 Holdings Mozart Manager L.L.C. | 51,548,391 | 0 | 51,548,391 | 0 | SCHEDULE 13G/A, 2026-08-07 |
| Bma Viii L.L.C. | 153,327,675 | 0 | 153,327,675 | 0 | SCHEDULE 13G/A, 2026-08-07 |
| Blackstone Holdings II L.P. | 153,327,675 | 0 | 153,327,675 | 0 | SCHEDULE 13G/A, 2026-08-07 |
| Blackstone Holdings I/II GP L.L.C. | 153,327,675 | 0 | 153,327,675 | 0 | SCHEDULE 13G/A, 2026-08-07 |
| Blackstone Inc. | 153,327,675 | 0 | 153,327,675 | 0 | SCHEDULE 13G/A, 2026-08-07 |
| Blackstone Group Management L.L.C. | 153,327,675 | 0 | 153,327,675 | 0 | SCHEDULE 13G/A, 2026-08-07 |
| Stephen A. Schwarzman | 153,327,675 | 0 | 153,327,675 | 0 | SCHEDULE 13G/A, 2026-08-07 |
| Hellman & Friedman Capital Partners X (Parallel), L.P. | 61,054,619 | — | 61,054,619 | — | SCHEDULE 13G/A, 2026-08-11 |
| HFCP X (Parallel - A), L.P. | 6,377,698 | — | 6,377,698 | — | SCHEDULE 13G/A, 2026-08-11 |
| Mend Partners II, L.P. | 3,422,699 | — | 3,422,699 | — | SCHEDULE 13G/A, 2026-08-11 |
| Mend Investment Holdings I, L.P. | 82,472,659 | — | 82,472,659 | — | SCHEDULE 13G/A, 2026-08-11 |
| Hellman & Friedman Investors X, L.P. | 153,327,675 | — | 153,327,675 | — | SCHEDULE 13G/A, 2026-08-11 |
| Mend Partners GP, LLC | 3,422,699 | — | 3,422,699 | — | SCHEDULE 13G/A, 2026-08-11 |
| Mend Investment Holdings GP, LLC | 82,472,659 | — | 82,472,659 | — | SCHEDULE 13G/A, 2026-08-11 |
| Hellman & Friedman Capital Partners X, L.P. | 82,472,659 | — | 82,472,659 | — | SCHEDULE 13G/A, 2026-08-11 |
The latest filing identifies Medline Inc. by CUSIP 58507V107 and gives its principal executive office as 3 Lakes Drive, Northfield, IL 60093 (SCHEDULE 13G/A, 2026-11-06).
What the percentages are based on
Each of the Reporting Persons may be deemed to be the beneficial owner of the percentage of shares of Class A Common Stock listed on such Reporting Person's cover page, calculated pursuant to Rule 13d-3 of the Act.Bma Viii L.L.C., SCHEDULE 13G/A, 2026-08-07
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-12-29 | GIC Private Limited | 14.64% | SCHEDULE 13G |
| 2026-02-11 | Abu Dhabi Investment Authority | 5.9% | SCHEDULE 13G |
| 2026-02-13 | Mozart Holdco, Inc. | 22.4% | SCHEDULE 13G |
| 2026-02-13 | Bma Viii L.L.C. | 24.4% | SCHEDULE 13G |
| 2026-02-13 | Hellman & Friedman Investors X, L.P. | 23.2% | SCHEDULE 13G |
| 2026-02-13 | Carlyle Group Inc. | 24.4% | SCHEDULE 13G |
| 2026-05-01 | Bma Viii L.L.C. | 20.6% | SCHEDULE 13G/A |
| 2026-05-06 | Hellman & Friedman Investors X, L.P. | 19.8% | SCHEDULE 13G/A |
| 2026-05-07 | Abu Dhabi Investment Authority | 4.9% | SCHEDULE 13G/A |
| 2026-05-15 | Carlyle Group Inc. | 20.6% | SCHEDULE 13G/A |
| 2026-08-06 | Fmr LLC | 5.5% | SCHEDULE 13G |
| 2026-08-07 | Bma Viii L.L.C. | 16.5% | SCHEDULE 13G/A |
| 2026-08-11 | Hellman & Friedman Investors X, L.P. | 16% | SCHEDULE 13G/A |
| 2026-10-30 | GIC Private Limited | 13.03% | SCHEDULE 13G/A |
| 2026-11-06 | GIC Private Limited | 8.49% | SCHEDULE 13G/A |
Questions about who owns Medline Inc.
Who owns Medline Inc.?
On this page, 6 holders' latest ownership filings report 5% or more of Medline Inc.: Mozart Holdco, Inc. (22.4%, Schedule 13G, filed 2026-02-13), Carlyle Group Inc. (20.6%, Schedule 13G/A, filed 2026-05-15), Bma Viii L.L.C. (16.5%, Schedule 13G/A, filed 2026-08-07), Hellman & Friedman Investors X, L.P. (16%, Schedule 13G/A, filed 2026-08-11) and GIC Private Limited (8.49%, Schedule 13G/A, filed 2026-11-06); 1 more is listed above.
Who are the largest shareholders of Medline Inc.?
By the share each holder's latest filing reports, the largest holders of Medline Inc. on this page are Mozart Holdco, Inc. (22.4%), Carlyle Group Inc. (20.6%) and Bma Viii L.L.C. (16.5%).
When did Mozart Holdco, Inc. buy into Medline Inc.?
The filings give report dates, not purchase dates. The earliest filing from Mozart Holdco, Inc. on this page is the Schedule 13G, filed 2026-02-13, reporting 22.4%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 15 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for Medline Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 15, 2026 | Leadership change: Joseph P. Baratta departs | — | Leadership changes | Source |
| July 9, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| May 26, 2026 | IPO filing, Form 424B4 | — | IPO filings | Source |
| May 20, 2026 | IPO filing, Form S-1 | — | IPO filings | Source |
| March 6, 2026 | IPO filing, Form 424B4 | $29 a share | IPO filings | Source |
| March 3, 2026 | IPO filing, Form S-1 | — | IPO filings | Source |
| December 18, 2025 | IPO filing, Form 424B4 | $29 a share | IPO filings | Source |
| December 8, 2025 | IPO filing, Form S-1/A | $26 to $30 a share | IPO filings | Source |
| November 4, 2025 | IPO filing, Form S-1/A | — | IPO filings | Source |
| October 28, 2025 | IPO filing, Form S-1 | — | IPO filings | Source |
Tools for this story
Each opens in a new tab, filled in for Medline Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.